We are hiring!

Strain identifier

BacDive ID: 147821

Type strain: No

Species: Proteus mirabilis

NCBI tax ID(s): 584 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 7.1 (current version):
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 7.1 (current version)

General

@ref: 52039

BacDive-ID: 147821

keywords: Bacteria

description: Proteus mirabilis CCUG 34294 is a bacterium that was isolated from Human vagina.

NCBI tax id

  • NCBI tax id: 584
  • Matching level: species

doi: 10.13145/bacdive147821.20221219.7.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/pseudomonadota
  • domain: Bacteria
  • phylum: Pseudomonadota
  • class: Gammaproteobacteria
  • order: Enterobacterales
  • family: Morganellaceae
  • genus: Proteus
  • species: Proteus mirabilis
  • full scientific name: Proteus mirabilis Hauser 1885 (Approved Lists 1980)

@ref: 52039

domain: Bacteria

phylum: Proteobacteria

class: Gammaproteobacteria

order: Enterobacterales

family: Morganellaceae

genus: Proteus

species: Proteus mirabilis

type strain: no

Physiology and metabolism

metabolite utilization

@refChebi-IDmetaboliteutilization activitykind of utilization tested
6837430911sorbitol-builds acid from
6837417057cellobiose-builds acid from
6837417268myo-inositol-builds acid from
6837462345L-rhamnose-builds acid from
6837427082trehalose+builds acid from
6837418333D-arabitol-builds acid from
6837430849L-arabinose-builds acid from
6837417992sucrose-builds acid from
6837417634D-glucose-builds acid from
6837427897tryptophan-energy source
6837415792malonate-assimilation
6837418394palatinose-builds acid from
6837415963ribitol-builds acid from
6837417306maltose-builds acid from
6837416899D-mannitol-builds acid from
68374Potassium 5-ketogluconate-builds acid from
6837418024D-galacturonic acid-builds acid from
6837418403L-arabitol-builds acid from
6837416199urea+hydrolysis
6837425094lysine-degradation
6837429016arginine-hydrolysis
6837418257ornithine+degradation

metabolite production

  • @ref: 68374
  • Chebi-ID: 35581
  • metabolite: indole
  • production: no

metabolite tests

  • @ref: 68374
  • Chebi-ID: 35581
  • metabolite: indole
  • indole test: -

enzymes

@refvalueactivityec
68374L-aspartate arylamidase+3.4.11.21
68374alpha-maltosidase-
68374alpha-galactosidase-3.2.1.22
68374alpha-glucosidase-3.2.1.20
68374beta-galactosidase-3.2.1.23
68374N-acetyl-beta-glucosaminidase-3.2.1.52
68374beta-glucuronidase-3.2.1.31
68374beta-glucosidase-3.2.1.21
68374lipase-
68374urease+3.5.1.5
68374lysine decarboxylase-4.1.1.18
68374arginine dihydrolase-3.5.3.6
68374ornithine decarboxylase+4.1.1.17

API ID32E

@refODCADH ArgLDC LysURELARLGAT5KGLIPRPbeta GLUMANMALADOPLEbeta GURMNTINDbeta NAGbeta GALGLUSACLARADARLalpha GLUalpha GALTRERHAINOCELSORalphaMALAspA
52039+--+---------------------+-----+

Isolation, sampling and environmental information

isolation

  • @ref: 52039
  • sample type: Human vagina
  • sampling date: 1970
  • geographic location: Florida
  • country: USA
  • origin.country: USA
  • continent: North America

isolation source categories

Cat1Cat2Cat3
#Host Body-Site#Urogenital tract#Vagina
#Host#Human#Female

External links

@ref: 52039

culture collection no.: CCUG 34294, NCDC 2059-70, ATCC 25933

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Pathogenicity22401914Semisynthesis and antimicrobial activity of novel guttiferone-A derivatives.Dias KS, Januario JP, D' Dego JL, Dias AL, dos Santos MH, Camps I, Coelho LF, Viegas C JrBioorg Med Chem10.1016/j.bmc.2012.02.0232012Anti-Bacterial Agents/*chemical synthesis/chemistry/*pharmacology, Antifungal Agents/*chemical synthesis/chemistry/*pharmacology, Bacteria/*drug effects/growth & development, Benzophenones/chemical synthesis/chemistry/*pharmacology, Cell Survival/drug effects, Dose-Response Relationship, Drug, Fungi/*drug effects/growth & development, Humans, Leukocytes, Mononuclear/cytology/drug effects, Microbial Sensitivity Tests, Molecular Conformation, Stereoisomerism, Structure-Activity Relationship
Pathogenicity28842740Lactococcus lactis as a safe and inexpensive source of bioactive silver composites.Viorica RP, Pawel P, Kinga M, Michal Z, Katarzyna R, Boguslaw BAppl Microbiol Biotechnol10.1007/s00253-017-8443-x2017Animals, Anti-Bacterial Agents/pharmacology, Lactococcus lactis/*metabolism, Metal Nanoparticles/*chemistry, Microbial Sensitivity Tests, Milk/microbiology, Nanocomposites/*chemistry, Proteus mirabilis/drug effects, Pseudomonas aeruginosa/drug effects, Silver/*pharmacology, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Spectroscopy, Fourier Transform Infrared, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effects, X-Ray DiffractionMetabolism
Pathogenicity32888099Intracellular biosynthesis of PbS quantum dots using Pseudomonas aeruginosa ATCC 27853: evaluation of antibacterial effects and DNA cleavage activities.Ocal N, Ceylan A, Duman FWorld J Microbiol Biotechnol10.1007/s11274-020-02917-z2020Anti-Bacterial Agents/*biosynthesis/chemistry/*pharmacology, Antifungal Agents/chemistry/pharmacology, Bacteria/drug effects, DNA Cleavage/*drug effects, Escherichia coli/drug effects, Fungi/drug effects, Lead/*chemistry, Microbial Sensitivity Tests, Microscopy, Electron, Transmission, Nanoparticles, Nanostructures/chemistry, Particle Size, Pseudomonas aeruginosa/*metabolism, Quantum Dots/chemistry/*metabolism, Spectrophotometry, Ultraviolet, Sulfides/*chemistry, X-Ray DiffractionMetabolism
Phylogeny33028279Isolation of endophytic bacteria from the leaves of Anredera cordifolia CIX1 for metabolites and their biological activities.Nxumalo CI, Ngidi LS, Shandu JSE, Maliehe TSBMC Complement Med Ther10.1186/s12906-020-03095-z2020Anti-Bacterial Agents/*pharmacology, Antioxidants/*pharmacology, Bacteria/*isolation & purification/*metabolism, *Endophytes, Plant Extracts/*pharmacology, Plant Leaves/*microbiology, Plants, Medicinal, South AfricaEnzymology
Pathogenicity34641314Bruguiera gymnorhiza (L.) Lam. at the Forefront of Pharma to Confront Zika Virus and Microbial Infections-An In Vitro and In Silico Perspective.Bibi Sadeer N, Haddad JG, Oday Ezzat M, Despres P, Abdallah HH, Zengin G, Uysal A, El Kalamouni C, Gallo M, Montesano D, Mahomoodally MFMolecules10.3390/molecules261957682021Anti-Bacterial Agents/chemistry/*pharmacology, Antifungal Agents/chemistry/*pharmacology, Antiviral Agents/chemistry/*pharmacology, Brazil, Candida albicans/drug effects/growth & development, Computer Simulation, Drug Synergism, Escherichia coli/drug effects/growth & development, Klebsiella pneumoniae/drug effects/growth & development, Mauritius, Microbial Sensitivity Tests, Microbial Viability/drug effects, Plant Extracts/chemistry/*pharmacology, Proteus mirabilis/drug effects/growth & development, Pseudomonas aeruginosa/drug effects/growth & development, Rhizophoraceae/*chemistry, Staphylococcus aureus/drug effects/growth & development, Zika Virus/drug effects/*growth & development
34946774Comparison of Phytochemical Contents, Antioxidant and Antibacterial Activities of Various Solvent Extracts Obtained from 'Maluma' Avocado Pulp Powder.Nguyen TV, Nguyen QD, Nguyen NN, Nguyen TTMolecules10.3390/molecules262476932021*Anti-Bacterial Agents/chemistry/pharmacology, *Antioxidants/chemistry/pharmacology, Bacteria/*growth & development, Persea/*chemistry, *Plant Extracts/chemistry/pharmacology

Reference

@idauthorstitledoi/urlcatalogue
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ10.1099/ijsem.0.004332
52039Curators of the CCUGhttps://www.ccug.se/strain?id=34294Culture Collection University of Gothenburg (CCUG) (CCUG 34294)
68374Automatically annotated from API ID32E